Market Highlights
- Kyowa Kirin North America, a Japanese life sciences enterprise, has unveiled plans for a $200.0 million investment in Helix Innovation Park at the Brickyard, located in Sanford.
- BioAgilytix, a clinical research firm in Durham, exited its agreement to create 878 jobs near Research Triangle Park due to a tough funding landscape for life sciences.
- Areteia Therapeutics, a pioneering biotechnology firm, secured $425.0 million in funding to advance the clinical development of its innovative asthma treatment across Japan and various international markets.